A new approach with LLT for very-high and extremely-high risk patients

 A new approach with LLT for veryhigh and extremelyhigh risk patients
5' education - May 6, 2021 - Prof. Maciej Banach, PhD, MD
  • Overview

    Based on a recent position paper endorsed by the International Lipid Expert Panel, prof. Banach discusses pathways of optimal lipid-lowering therapy in very-high and extremely-high risk patients.

  • Educational information

    This video was recorded in response to a recent publication in Pharmacological Research by prof. Banach and colleagues.

  • Faculty

    Prof. Maciej Banach, MD, PhD is a Full Professor of Cardiology at the Medical University of Lodz (MUL), Lodz, Poland.

  • Disclosures

    This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.

    Find this article online at Pharmacol Research.

    The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Facebook Comments


We’re glad to see you’re enjoying PACE-CME…
but how about a more personalized experience?

Register for free